期刊文献+

复发及难治性宫颈癌的诊断和治疗 被引量:7

下载PDF
导出
摘要 29%~38%的宫颈癌患者在治疗后复发或未控,复发或未控宫颈癌的5年生存率为3.2% ̄13%。75%以上的宫颈癌复发出现在初次治疗后的2年内,早期发现对预后非常重要,正电子发射断层扫描术(PET)是一种灵敏的影像学方法,有助于病灶的诊断和定位,复发及难治性宫颈癌的治疗主要根据病变程度、初次治疗方式以及复发病灶的形式和特点选择方案,以综合治疗为主,其中化疗以铂类药物联合化疗为主。
作者 彭萍 向阳
出处 《国外医学(妇产科学分册)》 2006年第4期250-252,共3页 Foreign Medical Sciences(Obstet Gynecol Fascicle)
  • 相关文献

参考文献19

  • 1Lai CH.Management of recurrent cervical cancer.Chang Gung Med J,2004,27(10):711-717
  • 2Yessaian A,Magistris A,Burger RA,et al.Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer:Feasibility and indications for adjuvant therapy.Obstet Gynecol Surv,2004,59(11):766-776
  • 3Hong JH,Tsai CS,Lai CH,et al.Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.Int J Radiat Oncol Biol Phys,2004,60(1):249-257
  • 4Disaia PJ,Creasman WT.Ed.Clinical Gynecol Oncol.6th edi,Mosby,Inc,2002,53-80
  • 5Havrilesky LJ,Kulasingam SL,Matchar DB,et al.PDG-PET for management of cervical and ovarian cancer.Gynecol Oncol,2005,97(1):183-191
  • 6Unger JB,Ivy JJ,Connor P,et al.Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women.Obstet Gynecol Surv,2005,60(1):29-31
  • 7Gallousis S.Isolated lung metastases from pelvic malignancies.Gynecol Oncol,1979,7(2):206-214
  • 8Moutardier V,Houvenaeghel G,Martino M,et al.Surgical resection of locally recurrent cervical cancer:a single institutional 70 patient serie.Int J Gynecol Cancer,2004,14(5):846-851
  • 9Hufner T,Kfuri M Jr,Galanski M,et al.New indications for computerassisted surgery:tumor resection in the pelvis.Clin Orthop Relat Res,2004,(426):219-225
  • 10Grigsby PW.Prospective phase Ⅰ/Ⅱ study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy.Int J Gynecol Cancer,2004,14(5):860-864

同被引文献67

  • 1方茵,田少雷,李克庆,赵树纬,王志远.抗肿瘤药物研究Ⅱ:去甲斑蝥素去氧脱氢类似物的合成与抗癌活性[J].药学学报,1993,28(12):931-935. 被引量:166
  • 2李华,章文华,张蓉,吴令英,李晓光,白萍.子宫颈腺癌159例预后影响因素分析[J].中华妇产科杂志,2005,40(4):235-238. 被引量:19
  • 3连丽娟.林巧稚妇科肿瘤学.第3版.北京:人民卫生出版社,2000,311-315.
  • 4Lai CH. Management of recurrent cervical cancer. Chang Gung Med J, 2004, 27(10):711-717.
  • 5Yessaian A, Magistris A, Burger RA, et al. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: Feasibility and indications for adjuvant therapy. Obstet Gynecol Surv, 2004, 59(11): 766-776.
  • 6Hong JH, Tsai CS, Lai CH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys, 2004, 60(1) : 249-257.
  • 7Kasamatsu T, Onda T, Yamada T, et al. Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma. Int J Gynaecol Obstet, 2005, 89 (1):39- 44.
  • 8Sakurai H, Mitsuhashi N, Takahashi M, et al. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis. Int J Radiat Oncol Biol Phys, 2001, 50 (5) : 1136-1144.
  • 9Nagao S, Fujiwara K, Oda T, et al. Combination chemotherapy of doeetaxel and earboplatin in advanced or recurrent cervix cancer. Apilot study. Gynecol Oncol, 2005, 96(3): 805-809.
  • 10Savarese A, Cognetti F. New drugs in the treatment of recurrent or metastatic cervical cancer. Crit Rev Oncol Hematol, 2003, 48 (3):323-327.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部